InnoCare Pharma
Manufacturing · New Jersey, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
103 Carnegie Ctr Ste 209, Princeton, New...Phone Number
(609) 524-0673Website
www.innocarepharma.comRevenue
$32.5 MillionIndustry
About InnoCare Pharma
诺诚健华 is focused on developing innovative drugs to address significant unmet clinical needs in the fields of malignant tumors and autoimmune diseases. The company possesses comprehensive research and commercialization capabilities, aiming to create first-in-class or best-in-class therapies for global markets. With a strong pipeline in hematological malignancies, autoimmune diseases, and solid tumors, 诺诚健华 is committed to delivering high-quality innovative medicines that benefit patients worldwide. The company is led by co-founder and CEO Dr. 崔霁松, who emphasizes the importance of scientific-driven innovation.Explore more
InnoCare Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to InnoCare Pharma
Compare insights from companies similar to InnoCare Pharma, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
InnoCare Pharma Tech Stack
A closer look at the technologies used by InnoCare Pharma
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding InnoCare Pharma
Sign Up For FreeTo access detailed company insights
诺诚健华 is focused on developing innovative drugs to address significant unmet clinical needs in the fields of malignant tumors and autoimmune diseases. The company possesses comprehensive research and commercialization capabilities, aiming to create first-in-class or best-in-class therapies for global markets. With a strong pipeline in hematological... Read More
